---
figid: PMC6787681__healthcare-07-00094-g004
figlink: /pmc/articles/PMC6787681/figure/healthcare-07-00094-f004/
number: Figure 4
caption: 'AT-rich interactive domain 1A (ARID1A) chromatin remodeling abnormalities
  in ovarian clear cell carcinoma (OCCC). ARID1A (green), a member of the switch/sucrose
  nonfermentable (SWI/SNF) complex (blue), works as a tumor suppressor through chromatin
  remodeling, DNA repair, and Myc inhibition. It also plays a role in the phosphoinositide
  3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway (red). ARID1A
  mutations are characteristic and frequent in OCCC, indicating its potential as an
  effective therapeutic target. Inhibitors of enhancer of zeste homolog 2 (EZH2) and
  bromodomain and extra-terminal domain protein (BET) induced synthetic lethality
  in ARID1A-mutated OCCC tumors via PI3K/AKT signaling (green). CDK1A: cyclin-dependent
  kinase inhibitor 1A.'
pmcid: PMC6787681
papertitle: 'Current Position of the Molecular Therapeutic Targets for Ovarian Clear
  Cell Carcinoma: A Literature Review.'
reftext: Tsukuru Amano, et al. Healthcare (Basel). 2019 Sep;7(3):94.
pmc_ranked_result_index: '134892'
pathway_score: 0.954088
filename: healthcare-07-00094-g004.jpg
figtitle: AT-rich interactive domain 1A (ARID1A) chromatin remodeling abnormalities
  in ovarian clear cell carcinoma (OCCC)
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6787681__healthcare-07-00094-g004.html
  '@type': Dataset
  description: 'AT-rich interactive domain 1A (ARID1A) chromatin remodeling abnormalities
    in ovarian clear cell carcinoma (OCCC). ARID1A (green), a member of the switch/sucrose
    nonfermentable (SWI/SNF) complex (blue), works as a tumor suppressor through chromatin
    remodeling, DNA repair, and Myc inhibition. It also plays a role in the phosphoinositide
    3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway (red). ARID1A
    mutations are characteristic and frequent in OCCC, indicating its potential as
    an effective therapeutic target. Inhibitors of enhancer of zeste homolog 2 (EZH2)
    and bromodomain and extra-terminal domain protein (BET) induced synthetic lethality
    in ARID1A-mutated OCCC tumors via PI3K/AKT signaling (green). CDK1A: cyclin-dependent
    kinase inhibitor 1A.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R4
  - PIK3CB
  - AKT3
  - PIK3CA
  - PIK3R3
  - AKT1
  - PIK3R5
  - PIK3CG
  - AKT2
  - ARID1A
  - PIK3CD
  - DNER
  - SMARCA1
  - MYC
  - CDKN1A
  - PIK3R6
  - EZH2
  - MTOR
genes:
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ARID1A
  symbol: ARID1A
  source: hgnc_symbol
  hgnc_symbol: ARID1A
  entrez: '8289'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: EZH2/BET
  symbol: bet
  source: hgnc_alias_symbol
  hgnc_symbol: DNER
  entrez: '92737'
- word: SWI/SNFcomplex
  symbol: SWI
  source: hgnc_alias_symbol
  hgnc_symbol: SMARCA1
  entrez: '6594'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: CDKN1A
  symbol: CDKN1A
  source: hgnc_symbol
  hgnc_symbol: CDKN1A
  entrez: '1026'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: EZH2/BETinhibitor
  symbol: EZH2
  source: hgnc_symbol
  hgnc_symbol: EZH2
  entrez: '2146'
- word: PI3K/AKT/MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals: []
diseases: []
---
